Chan Sau Hing, Chui Chung Hin, Chan Shun Wan, Kok Stanton Hon Lun, Chan Dessy, Tsoi Miriam Yuen Tung, Leung Polly Hang Mei, Lam Alfred King Yin, Chan Albert Sun Chi, Lam Kim Hung, Tang Johnny Cheuk On
State Key Laboratory of Chirosciences, State Key Laboratory of Chinese Medicine and Molecular Pharmacology (Shenzhen), Lo Ka Chung Centre for Natural Anti-Cancer Drug Development, Department of Applied Biology and Chemical Technology, The Hong Kong Polytechnic University , Hong Kong SAR, People's Republic of China.
Clinical Division, School of Chinese Medicine, Hong Kong Baptist University , Hong Kong SAR, People's Republic of China.
ACS Med Chem Lett. 2012 Dec 20;4(2):170-4. doi: 10.1021/ml300238z. eCollection 2013 Feb 14.
This letter describes the preparation of quinoline derivatives and their cytotoxic potentials toward human carcinoma cell lines. Among the selected compounds, 8-hydroxy-2-quinolinecarbaldehyde (3) showed the best in vitro cytotoxicity against the human cancer cell lines, including MDA231, T-47D, Hs578t, SaoS2, K562, SKHep1 (with a MTS50 range of 12.5-25 μg/mL) and Hep3B (with a MTS50 range of 6.25±0.034 μg/mL). The in vivo antitumor activity of compound 3 on subcutenaous Hep3B hepatocellular carcinoma xenograft in athymic nude mice was then studied. The results showed that the dose of 10 mg/kg/day of compound 3 with intraperitoneal injection for 9 days totally abolished the growth of the xenograft tumor of Hep3B with no histological damage on vital organs as compared with the control. The experimental results suggested that compound 3 has a good potential as an antitumor agent.
这封信描述了喹啉衍生物的制备及其对人癌细胞系的细胞毒性潜力。在所选化合物中,8-羟基-2-喹啉甲醛(3)对包括MDA231、T-47D、Hs578t、SaoS2、K562、SKHep1(MTS50范围为12.5 - 25μg/mL)和Hep3B(MTS50范围为6.25±0.034μg/mL)在内的人癌细胞系表现出最佳的体外细胞毒性。然后研究了化合物3对无胸腺裸鼠皮下Hep3B肝细胞癌异种移植瘤的体内抗肿瘤活性。结果表明,化合物3以10mg/kg/天的剂量腹腔注射9天,与对照组相比,完全抑制了Hep3B异种移植瘤的生长,且对重要器官无组织学损伤。实验结果表明化合物3具有作为抗肿瘤药物的良好潜力。